-
PRE-MARKET MOVERS:(MCRL),(MNTA),(CYAN),(RVSN)
Wednesday, February 16, 2011 - 10:06am | 34PRE-MARKET MOVERS:(MCRL),(MNTA),(CYAN),(RVSN)
-
Morgan Stanley Raises PT on Watson Pharmaceuticals to $63 (WPI)
Wednesday, February 16, 2011 - 9:50am | 122Morgan Stanley is out with its report today on Watson Pharmaceutical (NYSE: WPI), raising its price target from $61 to $63. In a note to clients, Morgan Stanley writes, "4Q results were essentially in line, and management reaffirmed 2011 guidance given at the January 21 Investor Day. We have...
-
Citi Discusses Sanofi, Genzyme Deal (SNY, GENZ)
Wednesday, February 16, 2011 - 9:47am | 231Citi Investment Research is out with a research report on the Sanofi-Aventis (NYSE: SNY), Genzyme (NASDAQ: GENZ) deal. Sanofi purchased Genzyme at a value of $74 per share, with a contingent value right (CVR) to be as high as $14 per share. In the note, Citi writes, "Combined with an additional...
-
A Peek Into The Market Before The Trading Starts
Wednesday, February 16, 2011 - 8:55am | 544Pre-open movers US stock futures are higher this morning, as investors are awaiting producer price data and FOMC minutes. Dell Inc (NASDAQ: DELL) reported upbeat quarterly earnings. Futures on the Dow Jones Industrial Average gained 33 points to 12,235 and S&P 500 futures rose 4.30 points to 1,...
-
Sanofi-aventis to Acquire Genzyme for $74 per Share Totaling $20.1B
Wednesday, February 16, 2011 - 8:25am | 102Sanofi-aventis (NYSE: SNY) and Genzyme Corporation (Nasdaq: GENZ) announced earlier today that they have entered into a definitive agreement under which sanofi-aventis is to acquire Genzyme for $74.00 per share in cash, or approximately $20.1 billion. In addition to the cash payment, each Genzyme...
-
US Stock Futures Up Ahead Of Producer Price Data, FOMC Minutes; Dell Reports Upbeat Earnings
Wednesday, February 16, 2011 - 7:30am | 458US stock futures are higher this morning, as Sanofi-Aventis SA (NYSE: SNY) agreed to purchase Genzyme Corp (NASDAQ: GENZ). Dell Inc (NASDAQ: DELL) reported upbeat quarterly earnings. Futures on the Dow Jones Industrial Average gained 30 points to 12,232.00 and S&P 500 futures rose 4.20 points...
-
Stocks To Watch For February 16 (GENZ, SNY, ADI, NVDA, DELL, FDO)
Wednesday, February 16, 2011 - 3:54am | 336Some of the stocks that may grab investor focus today are: Wall Street expects Genzyme Corp (NASDAQ: GENZ) to report its Q4 EPS at $0.86 on revenue of $1.17 billion. Sanofi-Aventis SA (NYSE: SNY) has agreed to purchase GENZ for around $20.1 billion in cash. SNY will pay $74 per share in cash plus a...
-
Stocks Going Ex Dividend the Fourth Week of February
Tuesday, February 15, 2011 - 11:31pm | 733Here is our latest update on the stock trading technique called 'Buying Dividends'. This is the process of buying stocks before the ex dividend date and selling the stock shortly after the ex date at about the same price, yet still being entitled to the dividend. This technique generally works only...
-
Narrow Trading Range 02-15-2011
Tuesday, February 15, 2011 - 7:29pm | 926Cusick's Corner The activity was tight today, as a matter of fact from a trading perspective it was a nothing day. The weakness in Crude continued. The Small Caps also showed some weakness on the close, while the market in general held critical levels of 1324 on the SPX. One market that I have...
-
Sanofi, Genzyme Deal As Soon As Tomorrow (SNY, GENZ)
Tuesday, February 15, 2011 - 2:20pm | 169The Wall Street Journal is reporting that a deal between Genzyme (NASDAQ: GENZ) and Sanofi-Aventis (NYSE: SNY) may be announced as soon as tomorrow. The two companies have agreed to a deal in principal, according to sources close to the situation. The deal values Genzyme at $74 per share for...
-
Calls Purchased on Spectrum Pharmaceuticals (SPPI)
Tuesday, February 15, 2011 - 2:04pm | 120Shares of Spectrum Pharmaceuticals (NASDAQ: SPPI) are higher on the session by 9.43%, currently trading at $7.07. The stock has been moving largely higher over the past six months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying calls on the name...
-
Bearish Positions Accumulate in Yum! Brands (NYSE:YUM)
Tuesday, February 15, 2011 - 12:35pm | 1788Yum! Brands (NYSE:YUM) is looking to shed two of its less-iconic brands (Long John Silver's and A&W) but a long-term investor seems to be adding to his or her own bearish position by scooping up LEAP ratio put spreads. The January 2013 40 and 45 puts were active on Monday and it was the second...
-
PRE-MARKET MOVERS (KOG),(VG),(GPS),(SPPI),(LPH),(EXK),(PZG)
Tuesday, February 15, 2011 - 10:27am | 58PRE-MARKET MOVERS (KOG),(VG),(GPS),(SPPI),(LPH),(EXK),(PZG)...
-
Bearish Sentiment on Teva Pharmaceuticals (NASDAQ:TEVA)
Tuesday, February 15, 2011 - 10:07am | 1864Teva Pharmaceuticals (NASDAQ:TEVA) hasn't had the greatest week as far as analyst opinion is concerned. Research analysts at Deutsche Bank reduced their 12-month price target on the stock to $64 from $66 on Wednesday, albeit keeping a “buy” rating on the shares. Elsewhere, Morgan Stanley lowered...
-
Affiliates of H.I.G. Capital Successfully Complete Tender Offer for Shares of Matrixx Initiatives
Tuesday, February 15, 2011 - 9:37am | 88Matrixx Initiatives, Inc. (Nasdaq: MTXX) and H.I.G. Capital, LLC today announced the successful completion of the tender offer for all of the outstanding shares of common stock of Matrixx by Wonder Holdings, Inc. and Wonder Holdings Acquisition Corp., both affiliates of H.I.G. formed for the...